United States · FDA National Drug Code directory
Haloperidol Decanoate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70756-615_b6a0b666-3e71-45a5-841e-af674068c7aa
- Product NDC
- 70756-615
- Form
- INJECTION
- Composition / generic term
- Haloperidol Decanoate
- Labeler
- Lifestar Pharma LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230523
- Source listing expiry
- 20271231
Source-listed ingredients
- HALOPERIDOL DECANOATE — 50 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL in 1 CARTON (70756-615-10) / 1 mL in 1 VIAL · 70756-615-10
- 3 VIAL in 1 CARTON (70756-615-33) / 1 mL in 1 VIAL · 70756-615-33
- 1 VIAL in 1 CARTON (70756-615-81) / 1 mL in 1 VIAL · 70756-615-81
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →